Overview

Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"

Status:
Completed
Trial end date:
2014-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of long-term treatment with pioglitazone (Actos Tablets) in the routine clinical setting in combination with an insulin product in patients with type 2 diabetes mellitus who responded inadequately when using an insulin product in addition to diet therapy and exercise therapy.
Details
Lead Sponsor:
Takeda
Treatments:
Insulin
Insulin, Globin Zinc
Pioglitazone